S&P 50 · Free
Thermo Fisher Scientific
TMO#MedicalDevicesHigh stock comp
Thermo Fisher Scientific trades at 21.80x forward earnings — 25% above peers (vs 19 peers in #MedicalDevices). Price $585.51.
- Forward P/E
- 21.80
- Industry median 17.41
- Current P/E
- 24.57
- Industry median 19.73
- Forward PEG
- 2.29
- Next fiscal year
- Opportunity Score
- 13
- Below average
Forward P/Edivides today's price by the earnings analysts expect Thermo Fisher Scientific to make over the next fiscal year — see what forward P/E measures for the full definition. Opportunity Score is a separate, slower 0–100 read on how attractive today looks as a historical entry point — see how it's built.
Consensus earnings run well above GAAP earnings, mostly through stock-based compensation. Ordinary for high-growth software, but it dilutes shareholders and makes any single earnings multiple a weaker signal.